These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31562193)

  • 1. Role of β-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish.
    Lelieveld LT; Mirzaian M; Kuo CL; Artola M; Ferraz MJ; Peter REA; Akiyama H; Greimel P; van den Berg RJBHN; Overkleeft HS; Boot RG; Meijer AH; Aerts JMFG
    J Lipid Res; 2019 Nov; 60(11):1851-1867. PubMed ID: 31562193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequences of excessive glucosylsphingosine in glucocerebrosidase-deficient zebrafish.
    Lelieveld LT; Gerhardt S; Maas S; Zwiers KC; de Wit C; Beijk EH; Ferraz MJ; Artola M; Meijer AH; Tudorache C; Salvatori D; Boot RG; Aerts JMFG
    J Lipid Res; 2022 May; 63(5):100199. PubMed ID: 35315333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1.
    Akiyama H; Kobayashi S; Hirabayashi Y; Murakami-Murofushi K
    Biochem Biophys Res Commun; 2013 Nov; 441(4):838-43. PubMed ID: 24211208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol.
    Akiyama H; Ide M; Nagatsuka Y; Sayano T; Nakanishi E; Uemura N; Yuyama K; Yamaguchi Y; Kamiguchi H; Takahashi R; Aerts JMFG; Greimel P; Hirabayashi Y
    J Biol Chem; 2020 Apr; 295(16):5257-5277. PubMed ID: 32144204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-glucosidase 1 (GBA1) is a second bile acid β-glucosidase in addition to β-glucosidase 2 (GBA2). Study in β-glucosidase deficient mice and humans.
    Harzer K; Blech-Hermoni Y; Goldin E; Felderhoff-Mueser U; Igney C; Sidransky E; Yildiz Y
    Biochem Biophys Res Commun; 2012 Jun; 423(2):308-12. PubMed ID: 22659419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes.
    Burke DG; Rahim AA; Waddington SN; Karlsson S; Enquist I; Bhatia K; Mehta A; Vellodi A; Heales S
    J Inherit Metab Dis; 2013 Sep; 36(5):869-72. PubMed ID: 23151684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The non-lysosomal β-glucosidase GBA2 is a non-integral membrane-associated protein at the endoplasmic reticulum (ER) and Golgi.
    Körschen HG; Yildiz Y; Raju DN; Schonauer S; Bönigk W; Jansen V; Kremmer E; Kaupp UB; Wachten D
    J Biol Chem; 2013 Feb; 288(5):3381-93. PubMed ID: 23250757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular β-glucosidases.
    Marques AR; Mirzaian M; Akiyama H; Wisse P; Ferraz MJ; Gaspar P; Ghauharali-van der Vlugt K; Meijer R; Giraldo P; Alfonso P; Irún P; Dahl M; Karlsson S; Pavlova EV; Cox TM; Scheij S; Verhoek M; Ottenhoff R; van Roomen CP; Pannu NS; van Eijk M; Dekker N; Boot RG; Overkleeft HS; Blommaart E; Hirabayashi Y; Aerts JM
    J Lipid Res; 2016 Mar; 57(3):451-63. PubMed ID: 26724485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease.
    Hamler R; Brignol N; Clark SW; Morrison S; Dungan LB; Chang HH; Khanna R; Frascella M; Valenzano KJ; Benjamin ER; Boyd RE
    Anal Chem; 2017 Aug; 89(16):8288-8295. PubMed ID: 28686011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease.
    Yildiz Y; Hoffmann P; Vom Dahl S; Breiden B; Sandhoff R; Niederau C; Horwitz M; Karlsson S; Filocamo M; Elstein D; Beck M; Sandhoff K; Mengel E; Gonzalez MC; Nöthen MM; Sidransky E; Zimran A; Mattheisen M
    Orphanet J Rare Dis; 2013 Sep; 8():151. PubMed ID: 24070122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a feedback loop involving β-glucosidase 2 and its product sphingosine sheds light on the molecular mechanisms in Gaucher disease.
    Schonauer S; Körschen HG; Penno A; Rennhack A; Breiden B; Sandhoff K; Gutbrod K; Dörmann P; Raju DN; Haberkant P; Gerl MJ; Brügger B; Zigdon H; Vardi A; Futerman AH; Thiele C; Wachten D
    J Biol Chem; 2017 Apr; 292(15):6177-6189. PubMed ID: 28258214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High β-glucosidase (GBA) activity not attributable to GBA1 and GBA2 in live normal and enzyme-deficient fibroblasts may emphasise the role of additional GBAs.
    Harzer K; Yildiz Y
    Biol Chem; 2015 Nov; 396(11):1241-6. PubMed ID: 25996484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucosylceramide and glucosylsphingosine metabolism in cultured fibroblasts deficient in acid beta-glucosidase activity.
    Sasagasako N; Kobayashi T; Yamaguchi Y; Shinnoh N; Goto I
    J Biochem; 1994 Jan; 115(1):113-9. PubMed ID: 8188616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of β-glucosidase 2 (GBA2) activity using lithocholic acid β-3-O-glucoside substrate for cultured fibroblasts and glucosylceramide for brain tissue.
    Harzer K; Yildiz Y; Beck-Wödl S
    Biol Chem; 2019 May; 400(6):745-752. PubMed ID: 30864417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.
    Cosden M; Jinn S; Yao L; Gretzula CA; Kandebo M; Toolan D; Hatcher NG; Ma L; Lemaire W; Adam GC; Burlein C; Minnick C; Flick R; Watt ML; Mulhearn J; Fraley M; Drolet RE; Marcus JN; Smith SM
    Neurobiol Dis; 2021 Nov; 159():105507. PubMed ID: 34509608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related neurochemical and behavioural changes in D409V/WT GBA1 mouse: Relevance to lewy body dementia.
    Clarke E; Jantrachotechatchawan C; Buhidma Y; Broadstock M; Yu L; Howlett D; Aarsland D; Ballard C; Francis PT
    Neurochem Int; 2019 Oct; 129():104502. PubMed ID: 31299418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the Zebrafish Homolog of β-Glucosidase 2: A Target of the Drug Miglustat.
    Sultana S; Truong NY; Vieira DB; Wigger JG; Forrester AM; Veinotte CJ; Berman JN; van der Spoel AC
    Zebrafish; 2016 Jun; 13(3):177-87. PubMed ID: 26909767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucosylated cholesterol in skin: Synthetic role of extracellular glucocerebrosidase.
    Boer DEC; Mirzaian M; Ferraz MJ; Nadaban A; Schreuder A; Hovnanian A; van Smeden J; Bouwstra JA; Aerts JMFG
    Clin Chim Acta; 2020 Nov; 510():707-710. PubMed ID: 32946792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.
    Barnes S; Xu YH; Zhang W; Liou B; Setchell KD; Bao L; Grabowski GA; Sun Y
    PLoS One; 2014; 9(12):e116023. PubMed ID: 25551612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells.
    Naito Y; Sakamoto S; Kojima T; Homma M; Tanaka M; Matsui H
    SLAS Discov; 2023 Oct; 28(7):344-349. PubMed ID: 37369311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.